News und Analysen
MannKind (MNKD) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
MannKind (NASDAQ: MNKD)Q2 2023 Earnings CallAug 07, 2023, 5:00 p.m. ET
Operator
Source Fool.com
Why BioNTech Stock Was Sinking Today
A monster revenue miss was the big reason for the widespread investor sell-off in BioNTech (NASDAQ: BNTX) stock on Monday. As of late-session trading that day, the once-hot biotech's share price had
Axsome Therapeutics (AXSM) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
Axsome Therapeutics (NASDAQ: AXSM)Q2 2023 Earnings CallAug 07, 2023, 8:00 a.m. ET
Operator
Source Fool.com
Why Sage Therapeutics Stock Is Crashing Today
Shares of Sage Therapeutics (NASDAQ: SAGE) were crashing 51.2% lower as of 11:27 a.m. ET on Monday. The huge sell-off came after the company and its partner, Biogen, announced following the market
2 Top Biotech Stocks to Buy in August
Last year was no small challenge for many investors, but the tides appear to have shifted for the better so far in 2023. Some companies have even performed well throughout all these ups and downs.
2 Top Stocks to Buy in August and Hold Forever
Technological progress sometimes renders products or entire industries completely obsolete. That's true even within the healthcare sector, which as a whole is unlikely to fall out of style anytime
1 Top Dividend Growth Stock to Buy on the Dip
Biotech giant Amgen (NASDAQ: AMGN) isn't having a great year. Its shares are down by 12% since 2023 started, and the company has faced several issues recently that have harmed its financial results
3 Fantastic Growth Stocks to Buy in August
What's a great thing to do during the hot month of August? One option is to find somewhere cool. Another is to invest in stocks that could deliver their own kind of sizzle.
We asked three Motley
Why Natera Stock Is Soaring Today
Shares of Natera (NASDAQ: NTRA) were soaring 18.7% higher at 11:04 a.m. ET on Friday. The big gain came after the DNA testing company announced its second-quarter results following the market close
If You Had Invested $5,000 in Amgen in 2013, This Is How Much You Would Have Today
Few other investment vehicles have arguably done more to enrich investors than the U.S. stock market. For example, A $5,000 investment in the S&P 500 index executed 10 years ago in 2013 would be
Does Abbott Laboratories' Dividend Make It a Buy?
When you're in the market for dividend income, it's important to keep your eye on the long term. An attractive payout today isn't worth much if the company might be forced to reduce or cut its
Is AbbVie Stock a Buy for Income Investors?
There are very few constants in life. But bills coming in on a routine basis is one of them. This is what makes income investing an appealing strategy for investors to generate the cash flow
Dynavax Technologies (DVAX) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
Dynavax Technologies (NASDAQ: DVAX)Q2 2023 Earnings CallAug 03, 2023, 4:30 p.m. ET
Operator
Source Fool.com
Geron (GERN) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
Geron (NASDAQ: GERN)Q2 2023 Earnings CallAug 03, 2023, 4:30 p.m. ET
Aron Feingold
Source Fool.com
Why Coherus BioSciences Stock Popped Today
Shares of Coherus BioSciences (NASDAQ: CHRS) soared 17.7% on Thursday, according to data provided by S&P Global Market Intelligence, after the biotech company announced better-than-expected
Cigna Group (CI) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
Cigna Group (NYSE: CI)Q2 2023 Earnings CallAug 03, 2023, 8:30 a.m. ET
Operator
Source Fool.com
Humana Foundation Announces 2023 Scholarship Awards
The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 41 years, today announced 81 winners of college scholarships awarded through the Humana Foundation Scholarship
Got $5,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond
The stock market is roaring back in 2023 following a downturn. However, the year hasn't been kind to every company. For instance, drugmakers AbbVie (NYSE: ABBV) and Axsome Therapeutics (NASDAQ:
3 Dividend Stocks That Hiked Payouts by 60% in Just 5 Years
Want a good dividend stock to own? Don't focus just on the yield itself. When it comes to long-term dividend income, it's important to consider businesses that are growing and that have the
3 High-Yielding Dividend Stocks to Buy and Hold for Decades
According to a recent Ipsos poll, one in five Americans don't expect to retire, and that's largely because they don't feel they can afford to do so. One way for Americans to improve their financial
This Is Arguably the Single Best Stock to Buy Right Now
What's the single best stock to buy right now? Ask five different investors and you'll probably get five different answers.
The problem, of course, is that defining what makes a given candidate the
Sarepta Therapeutics (SRPT) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
Sarepta Therapeutics (NASDAQ: SRPT)Q2 2023 Earnings CallAug 02, 2023, 4:30 p.m. ET
Operator
Source Fool.com
Why Shares of Nevro Are Down Wednesday
Shares of Nevro (NYSE: NVRO) were down more than 19% as of 3:30 p.m. ET on Wednesday after the company announced second-quarter earnings. The healthcare stock is down more than 49% so far this year
Karyopharm Therapeutics (KPTI) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
Karyopharm Therapeutics (NASDAQ: KPTI)Q2 2023 Earnings CallAug 02, 2023, 8:00 a.m. ET
Operator
Source Fool.com
Why Shares of Blueprint Medicines Are Falling Wednesday
Shares of Blueprint Medicines (NASDAQ: BPMC) were down more than 12% as of 12:45 p.m. on Wednesday after the healthcare company announced second-quarter earnings. The stock is still up more than 27%